CLU and cancer: Regardless of the complexity of CLU proteins and functions and their still incompletely understood influence on cell viability and apoptosis, a current strategy to optimize the treatment of androgen-independent prostate cancer is to minimize sCLU synthesis while leaving cytosolic CLU expression unaffected in order to make cancer cells more susceptible to chemotherapeutic drugs.